Evidence map›Paper›PMID 33123498›Full record

ArticleFrontiers in cellular and infection microbiology2020

Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.

Hebah A Al Khatib, Fatiha M Benslimane, Israa E Elbashir, Peter V Coyle, Muna A Al Maslamani, Abdullatif Al-Khal, Asmaa A Al Thani, Hadi M Yassine

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hebah A Al KhatibBiomedical Research Center, Qatar University, Doha, Qatar.
Fatiha M BenslimaneBiomedical Research Center, Qatar University, Doha, Qatar.
Israa E ElbashirBiomedical Research Center, Qatar University, Doha, Qatar.
Peter V CoyleVirology Laboratory, Hamad Medical Corporation, Doha, Qatar.
Muna A Al MaslamaniCommunicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Abdullatif Al-KhalCommunicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Asmaa A Al ThaniBiomedical Research Center, Qatar University, Doha, Qatar.
Hadi M YassineBiomedical Research Center, Qatar University, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Severity of Illness IndexAdultAgedBetacoronavirusConsensus SequenceCoronavirus InfectionsCOVID-19FemaleGenetic VariationGenome, ViralHumansMaleMiddle AgedPandemicsPneumonia, ViralRisk FactorsRNA, ViralCOVID-19 severitynonsynonymous mutationsSARS-CoV-2virus quasispecieswithin-host diversity

Identifiers

PMID33123498
PMCPMC7572854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.